Swedish Orphan Biovitrum AB (publ)

BIOVF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$4$3$3$3
Dep. & Amort.$4$3$2$2
Deferred Tax$0$0-$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$1-$1$1
Other Non-Cash-$1-$1-$0-$1
Operating Cash Flow$7$4$5$5
Investing Activities
PP&E Inv.-$0-$0-$1-$0
Net Acquisitions$0-$17$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$3-$5-$1-$0
Investing Cash Flow-$3-$22-$1-$0
Financing Activities
Debt Repay.-$4$11-$2-$4
Stock Issued$0$6$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$1-$0
Financing Cash Flow-$4$17-$3-$4
Forex Effect-$0-$0$0$0
Net Chg. in Cash$0-$0$0$1
Supplemental Information
Beg. Cash$1$1$1$0
End Cash$1$1$1$1
Free Cash Flow$4-$0$3$5